109 related articles for article (PubMed ID: 841673)
1. Variations in cryoprecipitate production.
Rock G; Tittley P
Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
[TBL] [Abstract][Full Text] [Related]
2. Preparation of cryoprecipitated factor VIII concentrates.
Slichter SJ; Counts RB; Henderson R; Harker LA
Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
[TBL] [Abstract][Full Text] [Related]
3. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
Wensley RT; Snape TJ
Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
[TBL] [Abstract][Full Text] [Related]
4. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
Vermeer C; Soute BA; Ates G; Brummelhuis HG
Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
[TBL] [Abstract][Full Text] [Related]
5. Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood.
Bloom AL; Giddings JC; Bevan B; Letton M; Drummond RJ
J Clin Pathol; 1969 Jul; 22(4):447-52. PubMed ID: 5798632
[TBL] [Abstract][Full Text] [Related]
6. Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII.
Foster PR; Dickson AJ; McQuillan TA; Dickson IH; Keddie S; Watt JG
Vox Sang; 1982; 42(4):180-9. PubMed ID: 6806984
[TBL] [Abstract][Full Text] [Related]
7. Severely heated therapeutic factor VIII concentrate of high specific activity.
Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
[TBL] [Abstract][Full Text] [Related]
8. Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability.
Brodniewicz-Proba T; Beauregard D
Vox Sang; 1987; 52(1-2):10-4. PubMed ID: 3111087
[TBL] [Abstract][Full Text] [Related]
9. Determinants of factor VIII recovery in cryoprecipitate.
Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
[TBL] [Abstract][Full Text] [Related]
10. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
Farrugia A; Prowse C
J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
[TBL] [Abstract][Full Text] [Related]
11. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
[TBL] [Abstract][Full Text] [Related]
12. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
13. Microwave-thawed plasma for cryoprecipitate production.
Bass H; Trenchard PM; Mustow MJ
Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
[TBL] [Abstract][Full Text] [Related]
14. An improved thaw-siphon method for the cryoprecipitate preparation.
Kang EP
Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
[TBL] [Abstract][Full Text] [Related]
15. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
de Wit HJ; Scheer G; Muradin J; van der Does JA
Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
[No Abstract] [Full Text] [Related]
17. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
Farrugia A; Griffin B; Pepper D; Prowse C
Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
[TBL] [Abstract][Full Text] [Related]
18. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
[TBL] [Abstract][Full Text] [Related]
19. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
Mazurier C; Samor B; Deromeuf C; Goudemand M
Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
[TBL] [Abstract][Full Text] [Related]
20. A protocol for the preparation of cryoprecipitate and cryodepleted plasma.
Sparrow RL; Greening DW; Simpson RJ
Methods Mol Biol; 2011; 728():259-65. PubMed ID: 21468954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
